Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1819cfd6331e1dc351a02c6cdae397ff |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_553ecf226d5e90ae149eb9360dc472b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c9c4cacede8b924787c7c76c3bfef26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a372de4f0c41ca3eebfa35e06af3b7ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feaccd9a4f2cb34ceb879f1b2c75a874 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7834aa868bd3a5063ba52fe7a17a2a11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40d86b678034e119b2f273d18d250da5 |
publicationDate |
2022-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114699441-A |
titleOfInvention |
Application of a traditional Chinese medicine composition comprising Yexiazhu, Yunzhi, Salvia miltiorrhiza and Lithospermum in the preparation of a medicine for inhibiting postoperative recurrence of liver cancer |
abstract |
The invention relates to the application of a traditional Chinese medicine composition containing Yexiazhu, Yunzhi, Salvia miltiorrhiza and comfrey in the preparation of a medicine for inhibiting postoperative recurrence of liver cancer. The traditional Chinese medicine composition is composed of the following medicinal materials in parts by weight: Yexiazhu 10 servings, 4 servings of Yunzhi, 1 serving of Salvia miltiorrhiza, and 1 serving of comfrey. The traditional Chinese medicine composition has a significant inhibitory effect on multiple liver cancer recurrence models, and has good therapeutic effect and safety. |
priorityDate |
2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |